Seroprevalence of SARS-CoV-2–Specific Antibodies Among Adults in Los Angeles County, California, on April 10-11, 2020
Neeraj Sood, Paul Simon, Peggy J. Ebner, Daniel Eichner, Jeffrey Reynolds, Eran Bendavid, Jay Bhattacharya
Abstract
allow strategically staffing the care of SARS-CoV-2-positive or patients suspected to be positive with seroconverted nurses and physicians. This study has limitations including a small sample size, short follow-up, lack of large-scale sensitivity/specificity of ELISA, lag of antibody positivity from PCR positivity, and the setting of a single pediatric dialysis unit.
Topics & Concepts
MedicineSeroprevalenceSeroconversionAsymptomaticSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Coronavirus disease 2019 (COVID-19)2019-20 coronavirus outbreakOutbreakPandemicVirologyAntibodyDiseaseImmunologyInfectious disease (medical specialty)Internal medicineSerologySARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesLong-Term Effects of COVID-19